Lotte Biologics Signs Additional CDMO Agreement with UK Ottimo Pharma
Second Consecutive Antibody Drug Manufacturing Agreement Signed Since Last June
Lotte Biologics announced on May 18 that it has signed a contract manufacturing agreement for antibody drugs with UK-based biotechnology company Ottimo Pharma.
Lotte Biologics also signed a contract manufacturing agreement for antibody drugs with Ottimo Pharma in June last year. Through this additional contract, Lotte Biologics will be responsible for producing the active pharmaceutical ingredient (API) for Ottimo Pharma's antibody drug candidate, Jankistomig, at the Syracuse Bio Campus in New York. This contract covers not only API production, but also process development.
James Park, CEO of Lotte Biologics, stated, "Based on our integrated CDMO capabilities that cover everything from process development to commercial manufacturing, we will actively support Ottimo Pharma in successfully developing new drugs."
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- Samsung Electronics Labor-Management Talks End Without Agreement... Central Labor Relations Commission: "Negotiations Resume at 10 a.m. Today" (Comprehensive)
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Spencer Fisk, Chief Technology and Quality Officer (CTQO) at Ottimo Pharma, commented, "Lotte Biologics' quick and reliable execution has played a vital role in enabling our clinical trials to proceed at an industry-leading pace. We are very pleased to further expand our collaboration as we continue development."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
